Condition
T2DM clinical trials and research
As of November 12, 2026, Find a Trial lists 10 T2DM clinical trials that are recruiting, at sites in 4 countries (most in China (7), Australia (1), United States (1)). By phase: Phase 2 (3), Phase 4 (1), Phase 3 (1), Early Phase 1 (1). There are also 12 NIH-funded research projects on T2DM, with $8.2 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 12NIH research projects
- 4Countries
Newest T2DM clinical trials
All recruiting trials (10)
-
HRS9531 tablets for adults with type 2 diabetes not controlled by lifestyle or metformin
This trial tests whether HRS9531 tablets help people with type 2 diabetes who have not reached their blood sugar goals on lifestyle changes or on metformin alone.
-
HM15275 in adults with type 2 diabetes who have not yet reached goal
This phase 2 trial tests HM15275 or a placebo to see if it helps adults with type 2 diabetes improve blood sugar over 36 weeks.
-
HTD1801 vs placebo for kidney protection in type 2 diabetes and CKD
This trial tests whether HTD1801 can slow kidney decline in adults with type 2 diabetes and chronic kidney disease.
-
Single-dose exenatide circular RNA in lipid nanoparticles for Chinese adults with type 2 diabetes
This test gives a single injection of CR059 (exenatide circular RNA in a lipid nanoparticle) to see if it is safe and how it behaves in Chinese adults with type 2 diabetes.
-
Adding empagliflozin to alogliptin and metformin for type 2 diabetes
This study tests whether adding empagliflozin to adults already taking alogliptin and metformin improves blood sugar control and is safe for people with type 2 diabetes who still have high blood sugar.
-
Cofrogliptin every two weeks added to metformin and dapagliflozin versus daily linagliptin for type 2 diabetes
This trial will test whether adding cofrogliptin every two weeks to metformin and dapagliflozin lowers HbA1c better than adding daily linagliptin in adults with type 2 diabetes whose blood sugar is not controlled on metformin plus an SGLT2 inhibitor.
-
Small-intestine calcium infusion to change gut function and blood sugar in men with type 2 diabetes
This trial will test whether delivering calcium directly into the upper small intestine during short clinic visits changes gut function and blood sugar in men with type 2 diabetes.
-
A system for preventing and controlling diabetic nephropathy
This study is trying to create a system to better understand and manage diabetic nephropathy by collecting data on risk factors and symptoms from a large group of people with diabetes.
-
Evaluation of GLP-1 receptor agonists for type 2 diabetes treatment
This study is trying to find out which GLP-1 medications work best for adults with type 2 diabetes and how safe and effective they are in real life.
-
Comparing Beinaglutide and Insulin for New Type 2 Diabetes Patients
This study is testing whether a new treatment called Beinaglutide works better than insulin for adults who have just been diagnosed with type 2 diabetes.
NIH-funded research (12)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Peer support to help older adults with type 2 diabetes in rural Appalachia
Seeing if trained peer support can help older adults in rural Appalachian communities better manage their type 2 diabetes.
-
Continuous Glucose Monitoring versus Traditional Self-Monitoring for Non-Insulin Treated Adults with Type 2 Diabetes
This grant tests whether wearing a CGM helps adults with type 2 diabetes who aren’t using insulin manage blood sugar better than traditional finger-stick checks.
-
Conditional cash transfers and basic needs support for adults with type 2 diabetes
A funding-backed program will test whether helping low-income adults with type 2 diabetes meet basic needs improves their diabetes control and overall health.
-
TREAT-T2DM: AI-powered help to titrate diabetes treatments
An AI tool called UpDoc Clinical Copilot helps manage diabetes medications remotely to improve blood sugar control for people with type 2 diabetes, especially in underserved communities.
-
Predicting heart and blood vessel disease risk in type 2 diabetes using immune-cell computer tools
This project uses new computer tools to read immune cell behavior and predict heart and blood vessel disease risk in people with type 2 diabetes.
-
Using cash incentives to improve health for African Americans with diabetes
This study is looking at how giving cash rewards for healthy activities can help African Americans with type 2 diabetes living in city neighborhoods improve their health and manage stress from poverty and racism.
-
Helping older adults with type 2 diabetes in Appalachia through peer support.
This study is all about helping older adults with type 2 diabetes in rural Appalachia by creating a friendly support program where they can share experiences and learn from each other to take better care of their health.
-
Assessing cardiovascular disease risk in patients with type 2 diabetes using advanced computational tools
This study is looking at how type 2 diabetes can increase the risk of heart disease by examining the role of certain immune cells, and it aims to find better ways to predict and manage this risk for people with diabetes.
-
How type 2 diabetes affects brain health and dementia risk
This study is looking at how not managing type 2 diabetes and prediabetes can affect brain health and memory in young adults aged 18 to 45, and it wants to find out if better diabetes management can help keep your mind sharp.
-
Exploring time-restricted eating as an alternative to calorie counting for managing type 2 diabetes
This study is looking at whether eating only during certain hours of the day can help people with type 2 diabetes who are overweight, and who take metformin, to better manage their blood sugar and lose weight, compared to counting calories.
-
Helping Hispanic/Latino patients with diabetes manage their emotions and improve health.
This study is all about helping Hispanic and Latino people with type 2 diabetes learn better ways to cope with their condition, using friendly techniques to improve their health and manage their diabetes more effectively.
-
Using low-dose pioglitazone to improve health outcomes in patients with type 2 diabetes and liver disease.
This study is looking at how early check-ups and treatment can help people with type 2 diabetes who might also have a liver condition called NASH, and it will teach doctors about the benefits of spotting this issue early and using a medication called pioglitazone to help improve liver health.
Related topics
Quick answers
How many T2DM clinical trials are recruiting right now?
10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (7 trials), Australia (1 trial), United States (1 trial), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 4: 1, Phase 3: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.